These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1657 related articles for article (PubMed ID: 26883400)
1. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. Sagaon-Teyssier L; Suzan-Monti M; Demoulin B; Capitant C; Lorente N; Préau M; Mora M; Rojas Castro D; Chidiac C; Chas J; Meyer L; Molina JM; Spire B; AIDS Care; 2016; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400 [TBL] [Abstract][Full Text] [Related]
2. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM; Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343 [TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L; Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274 [TBL] [Abstract][Full Text] [Related]
4. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis. Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366 [TBL] [Abstract][Full Text] [Related]
5. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM; Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965 [TBL] [Abstract][Full Text] [Related]
6. Changes in Sexual Behaviors in Men Who Have Sex with Men: A Comparison Between the Double-Blind and Open-Label Extension Phases of the ANRS-IPERGAY Trial. Di Ciaccio M; Sagaon-Teyssier L; Mimi M; Suzan-Monti M; Protiere C; Rojas Castro D; Meyer L; Tremblay C; Chidiac C; Capitant C; Préau M; Molina JM; Spire B; AIDS Behav; 2020 Nov; 24(11):3093-3106. PubMed ID: 32306213 [TBL] [Abstract][Full Text] [Related]
7. Does HIV Pre-Exposure Prophylaxis Modify the Effect of Partnership Characteristics on Condom Use? A Cross-Sectional Study of Sexual Partnerships Among Men Who Have Sex with Men in San Francisco, California. Prescott MR; Hern J; Petersen M; Santos GM AIDS Patient Care STDS; 2019 Apr; 33(4):167-174. PubMed ID: 30932698 [TBL] [Abstract][Full Text] [Related]
8. What are the situational and behavioral factors associated with condomless anal sex without pre-exposure prophylaxis in MSM? Di Ciaccio M; Sagaon-Teyssier L; Mimi M; Suzan-Monti M; Protiere C; Castro DR; Meyer L; Tremblay C; Chidiac C; Capitant C; Préau M; Molina JM; Spire B; AIDS; 2020 Jul; 34(9):1367-1375. PubMed ID: 32287072 [TBL] [Abstract][Full Text] [Related]
9. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG; Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098 [TBL] [Abstract][Full Text] [Related]
10. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study. Molina JM; Ghosn J; Assoumou L; Delaugerre C; Algarte-Genin M; Pialoux G; Katlama C; Slama L; Liegeon G; Beniguel L; Ohayon M; Mouhim H; Goldwirt L; Spire B; Loze B; Surgers L; Pavie J; Lourenco J; Ben-Mechlia M; Le Mestre S; Rojas-Castro D; Costagliola D; Lancet HIV; 2022 Aug; 9(8):e554-e562. PubMed ID: 35772417 [TBL] [Abstract][Full Text] [Related]
11. Reactions and Receptivity to Framing HIV Prevention Message Concepts About Pre-Exposure Prophylaxis for Black and Latino Men Who Have Sex with Men in Three Urban US Cities. Mimiaga MJ; Closson EF; Battle S; Herbst JH; Denson D; Pitts N; Holman J; Landers S; Mansergh G AIDS Patient Care STDS; 2016 Oct; 30(10):484-489. PubMed ID: 27749110 [TBL] [Abstract][Full Text] [Related]
12. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. Buchbinder SP; Glidden DV; Liu AY; McMahan V; Guanira JV; Mayer KH; Goicochea P; Grant RM Lancet Infect Dis; 2014 Jun; 14(6):468-75. PubMed ID: 24613084 [TBL] [Abstract][Full Text] [Related]
13. Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France. Lorente N; Fugon L; Carrieri MP; Andreo C; Le Gall JM; Cook E; Aboulker JP; Capitant C; Molina JM; Spire B AIDS Care; 2012; 24(4):468-77. PubMed ID: 22085083 [TBL] [Abstract][Full Text] [Related]
14. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. Laurent C; Dembélé Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traoré I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fayé-Ketté H; Koné A; Diandé S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B; Lancet HIV; 2021 Jul; 8(7):e420-e428. PubMed ID: 34048794 [TBL] [Abstract][Full Text] [Related]
15. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services. Liu AY; Cohen SE; Vittinghoff E; Anderson PL; Doblecki-Lewis S; Bacon O; Chege W; Postle BS; Matheson T; Amico KR; Liegler T; Rawlings MK; Trainor N; Blue RW; Estrada Y; Coleman ME; Cardenas G; Feaster DJ; Grant R; Philip SS; Elion R; Buchbinder S; Kolber MA JAMA Intern Med; 2016 Jan; 176(1):75-84. PubMed ID: 26571482 [TBL] [Abstract][Full Text] [Related]
16. Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin. Ahouada C; Diabaté S; Mondor M; Hessou S; Guédou FA; Béhanzin L; Batona G; Gning NN; Zannou DM; Alary M BMC Public Health; 2020 Aug; 20(1):1267. PubMed ID: 32819335 [TBL] [Abstract][Full Text] [Related]
17. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. Marcus JL; Glidden DV; Mayer KH; Liu AY; Buchbinder SP; Amico KR; McMahan V; Kallas EG; Montoya-Herrera O; Pilotto J; Grant RM PLoS One; 2013; 8(12):e81997. PubMed ID: 24367497 [TBL] [Abstract][Full Text] [Related]
18. Pre-Exposure Prophylaxis (PrEP) Use is Associated With Health Risk Behaviors Among Moderate- and Heavy-Drinking MSM. Luehring-Jones P; Palfai TP; Tahaney KD; Maisto SA; Simons J AIDS Educ Prev; 2019 Oct; 31(5):452-462. PubMed ID: 31550196 [TBL] [Abstract][Full Text] [Related]
19. Pre-exposure prophylaxis initiation and adherence among Black men who have sex with men (MSM) in three US cities: results from the HPTN 073 study. Wheeler DP; Fields SD; Beauchamp G; Chen YQ; Emel LM; Hightow-Weidman L; Hucks-Ortiz C; Kuo I; Lucas J; Magnus M; Mayer KH; Nelson LE; Hendrix CW; Piwowar-Manning E; Shoptaw S; Watkins P; Watson CC; Wilton L J Int AIDS Soc; 2019 Feb; 22(2):e25223. PubMed ID: 30768776 [TBL] [Abstract][Full Text] [Related]
20. Attitudes Towards PrEP and Anticipated Condom Use Among Concordant HIV-Negative and HIV-Discordant Male Couples. Hoff CC; Chakravarty D; Bircher AE; Campbell CK; Grisham K; Neilands TB; Wilson PA; Dworkin S AIDS Patient Care STDS; 2015 Jul; 29(7):408-17. PubMed ID: 26057304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]